Kaito K, Otsubo H, Takei Y, Usui N, Kobayashi M
Division of Hematology and Oncology, Department of Internal Medicine, Jikei University, School of Medicine, 3-19-18 Nishi Shinbashi, 105-8471 Minato-ku, Tokyo, Japan.
Ann Hematol. 2003 Nov;82(11):699-701. doi: 10.1007/s00277-003-0714-1. Epub 2003 Sep 5.
We describe a patient with typical hemophagocytic syndrome (HPS) in whom pancytopenia was refractory to steroid pulse therapy. He was successfully treated with immunosuppressive therapy using antithymocyte globulin (ATG) and cyclosporine (CyA), which is known to be effective for aplastic anemia (AA). Activation of histiocytes occurs in HPS as a response to several cytokines produced by activated T lymphocytes, while apoptosis of hematopoietic stem cells in AA is caused by T lymphocyte-derived cytokines. The response of this patient indicated that both diseases may have some similar immune-mediated conditions involving the activation of T lymphocytes and that intensive immunosuppressive therapy with ATG and CyA might be a useful strategy for steroid-resistant HPS.
我们描述了一名患有典型噬血细胞综合征(HPS)的患者,其全血细胞减少对类固醇冲击疗法无效。他通过使用抗胸腺细胞球蛋白(ATG)和环孢素(CyA)的免疫抑制疗法成功得到治疗,已知这两种药物对再生障碍性贫血(AA)有效。在HPS中,组织细胞的激活是对活化T淋巴细胞产生的多种细胞因子的反应,而AA中造血干细胞的凋亡是由T淋巴细胞衍生的细胞因子引起的。该患者的反应表明,这两种疾病可能存在一些涉及T淋巴细胞激活的相似免疫介导情况,并且使用ATG和CyA进行强化免疫抑制治疗可能是治疗类固醇抵抗性HPS的有效策略。